ARCHIVES

NCI Seeks CRADA Partners To Develop Targets Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 41 | October 24, 1997

Download PDF Visit The Full Archive

Related Articles

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976

Key Cancer Legislation Remains Unfinished as Congress Departs for Election.

October 6, 2006

To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates

March 31, 1995

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001